pharma · Social Anxiety Disorder · Drug Drug Interaction · VTGN
Vistagen Therapeutics
Vesigen Therapeutics is a pharma organization headquartered in Cambridge, USA. It trades on NYSE under ticker VTGN. Primary therapeutic focus areas include Social Anxiety Disorder, Drug Drug Interaction, Major Depressive
Cambridge, USA HQ
7 Employees
Public company Type
VTGN · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Employees
- 7
- Programs
- 10
- Drugs
- 3
- Patents
- 6
AV-101
Phase 2 · small molecule · Major Depressive Disorder
AV-101 for Major Depressive Disorder is a Phase 2 program (small_molecule) at Vistagen Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code VSG-CL 003
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Vistagen Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Major Depressive Disorder
- Status
- completed
- Trials
- 1